Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Alexander Drilon
Author Correction: HER Kinase Inhibition in Patients With HER2- And HER3-mutant Cancers
Nature
Multidisciplinary
Targeting RET-driven Cancers: Lessons From Evolving Preclinical and Clinical Landscapes
Nature Reviews Clinical Oncology
Oncology
Five-Year Survival and Correlates Among Patients With Advanced Melanoma, Renal Cell Carcinoma, or Non–Small Cell Lung Cancer Treated With Nivolumab
JAMA Oncology
Cancer Research
Oncology
RASA1 and NF1 Are Preferentially Co-Mutated and Define a Distinct Genetic Subset of Smoking-Associated Non-Small Cell Lung Carcinomas Sensitive to MEK Inhibition.
Clinical Cancer Research
Cancer Research
Oncology
Activation of KRAS Mediates Resistance to Targeted Therapy in MET Ex on 14 Mutant Non-Small Cell Lung Cancer
Clinical Cancer Research
Cancer Research
Oncology
Structural Insight Into Selectivity and Resistance Profiles of ROS1 Tyrosine Kinase Inhibitors
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Colorectal Carcinomas Containing Hypermethylated MLH1 Promoter and Wild Type BRAF/KRAS Are Enriched for Targetable Kinase Fusions
Cancer Research
Cancer Research
Oncology
Brief Report: Frequency of Brain Metastases and Multikinase Inhibitor Outcomes in Patients With RET -Rearranged Lung Cancers
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
A Prospective Study of Tumor Suppressor Gene Methylation as a Prognostic Biomarker in Surgically Resected Stage I to IIIA Non–Small-Cell Lung Cancers
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Complete Pathological Response to Crizotinib in a Patient With ALK-rearranged Lung Adenocarcinoma
Clinical Lung Cancer
Cancer Research
Oncology
Respiratory Medicine
Pulmonary
1
2
›
